Change in the number of votes relating to Biotie Therapies Corp.'s shares
(Thomson Reuters ONE) -
BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 2 September 2011 at 11
a.m.
Change in the number of votes relating to Biotie Therapies Corp.'s shares
The Swiss subsidiary of Biotie Therapies Corp. ("Biotie" or the "Company"),
Biotie Therapies Holding AG (previously Synosia Therapeutics Holding AG) has
conveyed Biotie shares Biotie shares against consideration pursuant to the
option programs as follows:
August 2011 Total Options outstanding % of the total amount of shares
(5-8/2011)
89,728 3,495,820 11,214,671 2.9
The conveyance of Biotie shares relates to the option plan of Synosia
Therapeutics Holding AG (currently Biotie Therapies Holding AG, "Synosia")
acquired by Biotie in February 2011. According to such Synosia share option
plan, options have been granted to employees, former directors and consultants.
In connection with the completion of the acquisition of Synosia, the option plan
was amended so that instead of shares in Synosia an aggregate maximum of
14,912,155 shares in Biotie may be subscribed based on the plan. Biotie issued
these 14,912,155 shares to its current subsidiary Synosia in connection with the
acquisition to be further conveyed to the option holders when they potentially
exercise their option rights in accordance with the terms and conditions of the
option program.
The conveyed shares previously held by the Company's subsidiary have not carried
any voting rights. The parent company Biotie does not own any treasury shares.
The conveyance does not affect the number of registered shares.
After the conveyances the changes are as follows:
The increase of A total amount of The number of the The total number of
vote of the voting rights: Company's share registered shares
Company held by the Group
August 2011 August 2011:
89,728 376,178,122 11,416,335 387,594,457
Turku, 2 September 2011
Biotie Therapies Corp.
Timo Veromaa
President and CEO
For further information, please contact:
Virve Nurmi, Biotie Therapies Corp.
tel. +358 2 274 8900
e-mail: virve.nurmi(at)biotie.com
DISTRIBUTION
NASDAQ OMX Helsinki Ltd
Main Media
www.biotie.com
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Biotie Therapies Oyj via Thomson Reuters ONE
[HUG#1543668]
Unternehmensinformation / Kurzprofil:
Datum: 02.09.2011 - 10:00 Uhr
Sprache: Deutsch
News-ID 61895
Anzahl Zeichen: 3234
contact information:
Town:
Turku
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 178 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Change in the number of votes relating to Biotie Therapies Corp.'s shares"
steht unter der journalistisch-redaktionellen Verantwortung von
Biotie Therapies Oyj (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
